€134.60
4.34% yesterday
L&S, Jul 05, 10:54 pm CET
ISIN
NL0012044747
Symbol
RDC
Index

Redcare Pharmacy Target price 2024 - Analyst rating & recommendation

Redcare Pharmacy Classifications & Recommendation:

Buy
67%
Hold
25%
Sell
8%

Redcare Pharmacy Price Target

Target Price €152.17
Price €134.70
Potential
Number of Estimates 12
12 Analysts have issued a price target Redcare Pharmacy 2025 . The average Redcare Pharmacy target price is €152.17. This is higher than the current stock price. The highest price target is
€190.00 41.05%
register free of charge
, the lowest is .
A rating was issued by 12 analysts: 8 Analysts recommend Redcare Pharmacy to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Redcare Pharmacy stock has an average upside potential 2025 of . Most analysts recommend the Redcare Pharmacy stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion € 1.80 2.38
49.36% 32.21%
EBITDA Margin 2.25% 2.92%
276.87% 29.53%
Net Margin -0.70% -0.39%
90.24% 44.38%

11 Analysts have issued a sales forecast Redcare Pharmacy 2024 . The average Redcare Pharmacy sales estimate is

€2.4b
Unlock
. This is
19.69% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€2.4b 22.21%
Unlock
, the lowest is
€2.3b 15.89%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €1.8b 49.36%
2024
€2.4b 32.21%
Unlock
2025
€2.9b 22.06%
Unlock
2026
€3.5b 19.65%
Unlock
2027
€4.0b 15.19%
Unlock
2028
€4.6b 15.81%
Unlock

11 Analysts have issued an Redcare Pharmacy EBITDA forecast 2024. The average Redcare Pharmacy EBITDA estimate is

€69.3m
Unlock
. This is
26.56% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€84.0m 11.02%
Unlock
, the lowest is
€58.3m 38.24%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €40.6m 364.17%
2024
€69.3m 70.98%
Unlock
2025
€118m 70.77%
Unlock
2026
€173m 45.98%
Unlock
2027
€277m 60.33%
Unlock
2028
€321m 15.97%
Unlock

EBITDA Margin

2023 2.25% 276.87%
2024
2.92% 29.53%
Unlock
2025
4.08% 39.73%
Unlock
2026
4.98% 22.06%
Unlock
2027
6.93% 39.16%
Unlock
2028
6.94% 0.14%
Unlock

9 Redcare Pharmacy Analysts have issued a net profit forecast 2024. The average Redcare Pharmacy net profit estimate is

€-9.2m
Unlock
. This is
7.89% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€7.4m 174.03%
Unlock
, the lowest is
€-21.6m 115.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €-12.6m 85.42%
2024
€-9.2m 26.90%
Unlock
2025
€24.6m 366.70%
Unlock
2026
€60.4m 145.42%
Unlock
2027
€125m 107.85%
Unlock
2028
€190m 51.73%
Unlock

Net Margin

2023 -0.70% 90.24%
2024
-0.39% 44.38%
Unlock
2025
0.85% 317.95%
Unlock
2026
1.74% 104.71%
Unlock
2027
3.14% 80.46%
Unlock
2028
4.11% 30.89%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share -0.63 -0.46
85.42% 26.98%
P/E negative
EV/Sales 1.16

9 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy <a href=/blog/eps>EPS is

€-0.46
Unlock
. This is
8.00% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
€0.37 174.00%
Unlock
, the lowest is
€-1.08 116.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €-0.63 85.42%
2024
€-0.46 26.98%
Unlock
2025
€1.23 367.39%
Unlock
2026
€3.01 144.72%
Unlock
2027
€6.27 108.31%
Unlock
2028
€9.51 51.67%
Unlock

P/E ratio

Current -270.21 828.24%
2024
-292.50 8.25%
Unlock
2025
109.67 137.49%
Unlock
2026
44.69 59.25%
Unlock
2027
21.50 51.89%
Unlock
2028
14.17 34.09%
Unlock

Based on analysts' sales estimates for 2024, the Redcare Pharmacy stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.38 15.34%
2024
1.16 16.19%
Unlock
2025
0.95 18.07%
Unlock
2026
0.79 16.42%
Unlock
2027
0.69 13.19%
Unlock
2028
0.59 13.64%
Unlock

P/S ratio

Current 1.36 9.83%
2024
1.13 16.45%
Unlock
2025
0.93 18.07%
Unlock
2026
0.78 16.41%
Unlock
2027
0.67 13.20%
Unlock
2028
0.58 13.65%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today